Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 22Head & Neck 11Gastrointestinal 8CNS 5Breast 5Gynecologic 3Other solid neoplasm 2Tumor-Agnostic 1Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 3

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Endostatins × Gynecologic × Clear all
NCT03086681 2025-07-29

ECWHCCFLACC

First Affiliated Hospital of Guangxi Medical University

Phase 2 Completed
120 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05879796 2023-05-30

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Peking University Third Hospital

Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
82 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡